Given the unique properties of nanoparticles, traditional safety assessment methods may not be sufficient. Advanced techniques, such as in vitro and in vivo studies, are employed to understand their interactions with biological systems. Regulatory bodies, such as the FDA and EPA, have specific guidelines for the assessment of nanomaterials to ensure they are safe for use in consumer products.
